SCWORX CORP (WORX)
US78396V2088 - Common Stock
Overall WORX gets a fundamental rating of 1 out of 10. We evaluated WORX against 37 industry peers in the Health Care Technology industry. WORX may be in some trouble as it scores bad on both profitability and health. WORX is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year WORX has reported negative net income.
In the past year WORX has reported a negative cash flow from operations.
In the past 5 years WORX always reported negative net income.
WORX had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -53.81%, WORX is not doing good in the industry: 72.22% of the companies in the same industry are doing better.
WORX's Return On Equity of -78.26% is in line compared to the rest of the industry. WORX outperforms 41.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -53.81% | ||
| ROE | -78.26% | ||
| ROIC | N/A |
ROA(3y)-41.73%
ROA(5y)-61.6%
ROE(3y)-63.35%
ROE(5y)-96.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
WORX has a worse Gross Margin (28.98%) than 83.33% of its industry peers.
WORX's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for WORX so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 28.98% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.73%
GM growth 5YN/A
2. Health
2.1 Basic Checks
WORX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for WORX has been increased compared to 1 year ago.
The number of shares outstanding for WORX has been increased compared to 5 years ago.
The debt/assets ratio for WORX has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of -5.82, we must say that WORX is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -5.82, WORX is doing worse than 80.56% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that WORX is not too dependend on debt financing.
WORX has a better Debt to Equity ratio (0.01) than 61.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -5.82 |
ROIC/WACCN/A
WACC8.85%
2.3 Liquidity
A Current Ratio of 0.33 indicates that WORX may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.33, WORX is doing worse than 91.67% of the companies in the same industry.
WORX has a Quick Ratio of 0.33. This is a bad value and indicates that WORX is not financially healthy enough and could expect problems in meeting its short term obligations.
WORX's Quick ratio of 0.33 is on the low side compared to the rest of the industry. WORX is outperformed by 91.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.33 | ||
| Quick Ratio | 0.33 |
3. Growth
3.1 Past
The earnings per share for WORX have decreased strongly by -65.42% in the last year.
Looking at the last year, WORX shows a very negative growth in Revenue. The Revenue has decreased by -17.96% in the last year.
WORX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 90.92% yearly.
EPS 1Y (TTM)-65.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.16%
Revenue 1Y (TTM)-17.96%
Revenue growth 3Y-9.95%
Revenue growth 5Y90.92%
Sales Q2Q%-16.51%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for WORX. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
WORX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SCWORX CORP
NASDAQ:WORX (11/25/2024, 8:00:02 PM)
After market: 2.98 -0.02 (-0.67%)3
+0.9 (+42.86%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.89M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -53.81% | ||
| ROE | -78.26% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 28.98% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.33 | ||
| Quick Ratio | 0.33 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-65.42%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-17.96%
Revenue growth 3Y-9.95%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y